Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report

Philadelphia chromosome‐positive acute myeloid leukemia (Ph + AML) is a rare type of AML with a low survival rate and poor prognosis. We first report a Ph + AML patient who remained in long‐term remission after the combination of flumatinib and venetoclax, which could provide corresponding treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Si‐Man, Tao, Tao, Wan, Chao‐Ling, Wu, Tian‐Mei, Cao, Han‐Yu, Qiu, Yan, Shen, Xiang‐Dong, Wang, Bin‐Ru, Ge, Shuai‐Shuai, Li, Yan‐Yan, Zhang, Tong‐Tong, Wu, Bing, Xue, Sheng‐Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810787/
https://www.ncbi.nlm.nih.gov/pubmed/36619491
http://dx.doi.org/10.1002/ccr3.6688
_version_ 1784863381108293632
author Huang, Si‐Man
Tao, Tao
Wan, Chao‐Ling
Wu, Tian‐Mei
Cao, Han‐Yu
Qiu, Yan
Shen, Xiang‐Dong
Wang, Bin‐Ru
Ge, Shuai‐Shuai
Li, Yan‐Yan
Zhang, Tong‐Tong
Wu, Bing
Xue, Sheng‐Li
author_facet Huang, Si‐Man
Tao, Tao
Wan, Chao‐Ling
Wu, Tian‐Mei
Cao, Han‐Yu
Qiu, Yan
Shen, Xiang‐Dong
Wang, Bin‐Ru
Ge, Shuai‐Shuai
Li, Yan‐Yan
Zhang, Tong‐Tong
Wu, Bing
Xue, Sheng‐Li
author_sort Huang, Si‐Man
collection PubMed
description Philadelphia chromosome‐positive acute myeloid leukemia (Ph + AML) is a rare type of AML with a low survival rate and poor prognosis. We first report a Ph + AML patient who remained in long‐term remission after the combination of flumatinib and venetoclax, which could provide corresponding treatment ideas for clinical practice.
format Online
Article
Text
id pubmed-9810787
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98107872023-01-05 Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report Huang, Si‐Man Tao, Tao Wan, Chao‐Ling Wu, Tian‐Mei Cao, Han‐Yu Qiu, Yan Shen, Xiang‐Dong Wang, Bin‐Ru Ge, Shuai‐Shuai Li, Yan‐Yan Zhang, Tong‐Tong Wu, Bing Xue, Sheng‐Li Clin Case Rep Case Report Philadelphia chromosome‐positive acute myeloid leukemia (Ph + AML) is a rare type of AML with a low survival rate and poor prognosis. We first report a Ph + AML patient who remained in long‐term remission after the combination of flumatinib and venetoclax, which could provide corresponding treatment ideas for clinical practice. John Wiley and Sons Inc. 2023-01-03 /pmc/articles/PMC9810787/ /pubmed/36619491 http://dx.doi.org/10.1002/ccr3.6688 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Huang, Si‐Man
Tao, Tao
Wan, Chao‐Ling
Wu, Tian‐Mei
Cao, Han‐Yu
Qiu, Yan
Shen, Xiang‐Dong
Wang, Bin‐Ru
Ge, Shuai‐Shuai
Li, Yan‐Yan
Zhang, Tong‐Tong
Wu, Bing
Xue, Sheng‐Li
Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report
title Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report
title_full Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report
title_fullStr Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report
title_full_unstemmed Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report
title_short Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report
title_sort flumatinib plus venetoclax as an effective therapy for philadelphia chromosome‐positive acute myeloid leukemia: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810787/
https://www.ncbi.nlm.nih.gov/pubmed/36619491
http://dx.doi.org/10.1002/ccr3.6688
work_keys_str_mv AT huangsiman flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport
AT taotao flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport
AT wanchaoling flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport
AT wutianmei flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport
AT caohanyu flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport
AT qiuyan flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport
AT shenxiangdong flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport
AT wangbinru flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport
AT geshuaishuai flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport
AT liyanyan flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport
AT zhangtongtong flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport
AT wubing flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport
AT xueshengli flumatinibplusvenetoclaxasaneffectivetherapyforphiladelphiachromosomepositiveacutemyeloidleukemiaacasereport

Ejemplares similares